Pure Global AI
Disease / condition

Idiopathic Pulmonary Fibrosis clinical trials

Free access to 305 studies10+ countriesUpdated daily72 recruiting
VerifiedClinicalTrials.gov · WHO ICTRP · regional registries
305
Total trials
10+
Countries
10+
Sponsors
72
Recruiting
By phase
N/A122
Phase 271
Phase 156
Phase 330
Early Phase 112
By status
Completed137
Recruiting72
Not yet recruit...34
Unknown20
Terminated19
Top countries
United States of America75
China28
United Kingdom25
France11
Germany7
Top sponsors
Boehringer Ingelhe...31
Hoffmann-La Roche15
Royal Brompton & H...8
GlaxoSmithKline6
Actelion5
Recent trials
Latest clinical trials for Idiopathic Pulmonary Fibrosis
A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)
Boehringer Ingelheim
NCT06335303Not yet recr...
Phase
Phase 2
A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
GlaxoSmithKline
NCT06317285Not yet recr...
Phase
Phase 2
The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis
University of Virginia
NCT06323876Not yet recr...
Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect
Hal Chapman · United States of America
NCT06265532Recruiting
Phase
Phase 1
A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.
Shanghai Synvida Biotechnology... · China
NCT06267183Recruiting
Phase
Phase 1
Biomarker Modulation and the Inhibition of NKT1 Cells by Oral GRI-0621 in Patients With IPF
GRI Bio Operations, Inc. · United States of America
NCT06331624Recruiting
Phase
Phase 2
A Study in People With Idiopathic Pulmonary Fibrosis to Test Whether Pirfenidone Influences the Amount of BI 1015550 in the Blood
Boehringer Ingelheim
NCT06241560Not yet recr...
Phase
Phase 1
Safety, Tolerability and Efficacy of VUM02 Injection in Treatment of Idiopathic Pulmonary Fibrosis (IPF)
Wuhan Optics Valley Vcanbiopha... · China
NCT06230822Recruiting
Phase
Phase 1
Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Syndax Pharmaceuticals
NCT06132256Not yet recr...
Phase
Phase 2
Safety, Tolerability and Pharmacokinetic Study of SC1011 in Healthy Subjects
Guangzhou JOYO Pharma Co., Ltd · China
NCT06135363Completed
Phase
Phase 1
SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
Guangzhou JOYO Pharma Co., Ltd · China
NCT06125327Recruiting
Phase
Phase 2/3
Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis
Pliant Therapeutics, Inc. · Australia,United States of America
NCT06097260Recruiting
Phase
Phase 2
Untitled Trial
Bristol Myers Squibb · United States of America
jRCT2021230026Recruiting
A Clinical Study to Evaluate the Efficacy and Safety of REGEND001 Cell Therapy on Idiopathic Pulmonary Fibrosis (IPF)
Regend Therapeutics · China
NCT06081621Recruiting
Phase
Phase 2
The Effect of N115 on Coughing in IPF Patients
Cellular Sciences, inc. · United States of America
NCT06037408Recruiting
Phase
Phase 3
Heart Rate Variability and Nocturnal Blood Oxygen Saturation in Patients With Idiopathic Pulmonary Fibrosis
Taipei Veterans General Hospit... · Taiwan
NCT06027372Recruiting
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
Bristol-Myers Squibb · Argentina,Australia,Austria,Belgium,Brazil,Canada,Chile,China,Colombia,Czech,Denmark,Finland,France,
NCT06003426Recruiting
Phase
Phase 3
Open-Label Dose-Escalation Treatment Study of Patients With IPF
Joseph C. Wu · United States of America
NCT05988463Not yet recr...
Phase
Phase 1
A Clinical Trial on the Treatment of Idiopathic Pulmonary Fibrosis
Beijing Tide Pharmaceutical Co...
NCT06102083Not yet recr...
Phase
Phase 2
Safety and Efficacy of Venetoclax in Idiopathic Pulmonary Fibrosis
University of Alabama at Birmi... · United States of America
NCT05976217Not yet recr...
Phase
Phase 1
View all 305 trials →
About this profile

Access comprehensive clinical trial information for Idiopathic Pulmonary Fibrosis through Pure Global AI's free database. This collection includes 305 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 72 trials are actively recruiting participants.

Research for Idiopathic Pulmonary Fibrosis is being conducted in United States of America, China, United Kingdom and 7+ other countries. Leading sponsors include Boehringer Ingelheim and Hoffmann-La Roche. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 305 clinical trials studying Idiopathic Pulmonary Fibrosis, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Boehringer Ingelheim, Hoffmann-La Roche, Royal Brompton & Harefield NHS Foundation Trust, among others.